BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2502417)

  • 1. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    Mölgaard J; von Schenck H; Olsson AG
    Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.
    Mölgaard J; Lundh BL; von Schenck H; Olsson AG
    Atherosclerosis; 1991 Dec; 91 Suppl():S21-8. PubMed ID: 1789813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Stohler R; Keller U; Riesen WF
    Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
    Ytre-Arne K; Nordøy A
    J Intern Med; 1989 Nov; 226(5):285-90. PubMed ID: 2681508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
    Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with simvastatin compared with cholestyramine.
    Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ
    Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
    Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA
    Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.
    Ebeling T; Turtola H; Voutilainen E; Uusitupa M; Pyörälä K; Reijonen T
    Ann Med; 1992 Apr; 24(2):121-7. PubMed ID: 1610539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
    Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).
    Simons LA
    Aust N Z J Med; 1998 Jun; 28(3):327-33. PubMed ID: 9673745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.
    Mölgaard J; von Schenck H; Olsson AG
    Eur Heart J; 1988 May; 9(5):541-51. PubMed ID: 3402470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
    Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
    J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
    Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
    Deslypere JP
    Acta Cardiol; 1989; 44(5):379-88. PubMed ID: 2690545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia.
    Emmerich J; Aubert I; Bauduceau B; Dachet C; Chanu B; Erlich D; Gautier D; Jacotot B; Rouffy J
    Eur Heart J; 1990 Feb; 11(2):149-55. PubMed ID: 2178931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ; Stuyt PM; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin (MK 733): an effective treatment for hypercholesterolemia.
    Lintott CJ; Scott RS; Nye ER; Robertson MC; Sutherland WH
    Aust N Z J Med; 1989 Aug; 19(4):317-20. PubMed ID: 2675812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.